ATHLONE, Ireland & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Innocoll Holdings Limited (“Innocoll”), a specialty pharmaceutical company wholly owned by Gurnet Point Capital, announced...
Read More
About Innocoll
Innocoll is a specialty pharmaceutical company committed to improving the status quo and finding answers to unmet needs
XARACOLL®
Our lead investigational product is a drug-device surgical implant being developed for potential uses in addressing postsurgical pain